Patent. JP6479818B2 【IF: 0】Patent. JP6479818B2 2019 Mar 06 INCB18424 purchased from AbMole
Patent. US10265258B2 【IF: 0】Patent. US10265258B2 2019 Apr 23 Tofacitinib purchased from AbMole
Patent. US10335380B2 【IF: 0】Patent. US10335380B2 2019 Jul 02 INCB18424 purchased from AbMole
Patent. CN109679915A 【IF: 0】Patent. CN109679915A 2019 Apr 26 Y-27632 dihydrochloride purchased from AbMole
【IF: 0】US Patent. 2019 Jul 30 Talazoparib purchased from AbMole
Patent. CN109837242A 【IF: 0】Patent. CN109837242A 2019 Jun 04 Y-27632 dihydrochloride purchased from AbMole
Patent. US2019367872A1 【IF: 0】Patent. US2019367872A1 2019 Dec 05 Y-27632 dihydrochloride purchased from AbMole
Patent. CN110551218A 【IF: 0】Patent. CN110551218A 2019 Dec 10 BTTAA purchased from AbMole
Patent. CN109825579A 【IF: 0】Patent. CN109825579A 2019 May 31 LY294002 purchased from AbMole
Patent. US10363264B2 【IF: 0】Patent. US10363264B2 2019-07-30 Talazoparib purchased from AbMole
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity 【IF: 64.5】Cell. 2018 Jan 11;172(1-2):373-386.e10 Y-27632 dihydrochloride purchased from AbMole
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids. 【IF: 64.5】Cell. 2018 Nov 29;175(6):1591-1606.e19 Y-27632 dihydrochloride purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
